Thursday, March 28, 2024

Bharat Biotech

Covaxin triggers higher antibody response in kids than adults: Bharat Biotech cites trial data

Express News Service NEW DELHI: Days after the government announced that 15 to 17-year-olds in India will be eligible for the Covid vaccine -- only Covaxin...

Covaxin 77.8 per cent effective against COVID, 65.2 per cent against Delta variant: Study

By PTI HYDERABAD: Bharat Biotech's vaccine Covaxin has demonstrated that it is 77.8 per cent effective against symptomatic Covid-19, through evaluation of 130 confirmed...

Ideal time for booster dose for COVID vaccine is 6 months after second dose: Bharat Biotech MD

By PTI NEW DELHI: The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman...

Bharat Biotech’s US partner Ocugen files request with FDA for Covaxin trials

By PTI HYDERABAD: Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to...

WHO may approve Bharat Biotech’s Covaxin ‘within 24 hours: Official

The Hyderabad-based Bharat Biotech had applied to the WHO on April 19 for Covaxin's Emergency Use Listing (EUL).

‘Can’t cut corners’: WHO seeks more data on Covaxin before decision on emergency use listing

By Express News Service NEW DELHI: The wait for emergency use listing (EUL) of COVID-19 vaccine Covaxin by the World Health Organisation is set...

Intranasal Covid vaccine trials to likely end soon

By Express News Service NEW DELHI: After receiving go-ahead for Covaxin for the two-years plus population by the drug regulator’s expert panel, Bharat Biotech...

Covid: Expert panel recommends emergency use approval for Covaxin in 2 to 18 age group

By PTI NEW DELHI: An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children...

Expert panel endorses Covaxin for kids, vaccine may come in pre-filled syringes

Express News Service NEW DELHI: An expert panel on Covid under the country’s apex drug regulator has approved administering Covaxin for kids and adolescents, paving the...

Bharat Biotech submits paediatric Covid vaccine data

Express News Service BENGALURU: Bharat Biotech, the developer of the indigenously developed Covid-19 vaccine Covaxin, is said to have submitted its Phase II/III clinical trials data...

Latest News

Lok Sabha Elections: Shiv Sena (UBT) firm on contesting from Sangli, nobody should do anything that will help BJP: Sanjay Raut

MUMBAI: Shiv Sena (UBT) leader Sanjay Raut on Thursday said that his party was firm on contesting from Maharashtra's...